Provention Bio, Inc. (NASDAQ:PRVB) Forecast to gain 109.16% to hit Consensus price target

Retrieved on: 2021-07-06 12:56:15

Tags for this article:

Stock market

Equity securities

Corporate finance

Initial public offering

Click the tags to see associated articles and topics

Provention Bio, Inc. (NASDAQ:PRVB) Forecast to gain 109.16% to hit Consensus price target. View article details on hiswai:

Excerpt

As of March 30, 2021, Blackrock Inc. held 7.04% of shares outstanding. The other major institutional holder is Gilder, Gagnon, Howe & Co., with the ...

Article found on: marketingsentinel.com

View Original Article